| Gastric cancer: prevention, risk factors and treatment H Zali, M Rezaei-Tavirani, M Azodi Gastroenterology and Hepatology from bed to bench 4 (4), 175, 2011 | 188 | 2011 |
| Personalized medicine in breast cancer: pharmacogenomics approaches S Jeibouei, ME Akbari, A Kalbasi, AR Aref, M Ajoudanian, A Rezvani, ... Pharmacogenomics and personalized medicine, 59-73, 2019 | 88 | 2019 |
| Biofabrication of chitosan/chitosan nanoparticles/polycaprolactone transparent membrane for corneal endothelial tissue engineering T Tayebi, A Baradaran-Rafii, A Hajifathali, A Rahimpour, H Zali, ... Scientific Reports 11 (1), 7060, 2021 | 56 | 2021 |
| Meningioma protein-protein interaction network H Zali, TM REZAEI ARCHIVES OF IRANIAN MEDICINE 17 (4), 262-272, 2014 | 56 | 2014 |
| Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer's disease H Zali, M Zamanian-Azodi, MR Tavirani, AA Baghban Iranian journal of pharmaceutical research: IJPR 14 (1), 291, 2015 | 54 | 2015 |
| Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach Z Molavi, S Razi, SA Mirmotalebisohi, A Adibi, M Sameni, F Karami, ... Biomedicine & Pharmacotherapy 138, 111544, 2021 | 53 | 2021 |
| Proteomics analysis of MKN45 cell line before and after treatment with Lavender aqueous extract M Zamanian-Azodi, M Rezaie-Tavirani, S Heydari-Kashal, S Kalantari, ... Gastroenterology and Hepatology from bed to bench 5 (1), 35, 2012 | 48 | 2012 |
| HSP90 and co-chaperones: impact on tumor progression and prospects for molecular-targeted cancer therapy A Jafari, M Rezaei-Tavirani, B Farhadihosseinabadi, S Taranejoo, H Zali Cancer Investigation 38 (5), 310-328, 2020 | 47 | 2020 |
| The risk factors of gestational diabetes mellitus: a systematic review and meta-analysis study F Kiani, MSG Naz, F Sayehmiri, K Sayehmiri, H Zali diabetes 10, 17, 2017 | 43 | 2017 |
| Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin A Jafari, M Rezaei-Tavirani, B Farhadihosseinabadi, H Zali, H Niknejad Stem Cell Research & Therapy 12 (1), 126, 2021 | 40 | 2021 |
| Aqueous extract of Lavender angustifolia inhibits lymphocytes proliferation of Hodgkin's lymphoma patients S Dalilan, M Rezaei-Tavirani, M Nabiuni, S Heidari-Keshel, MZ Azodi, ... Iranian journal of cancer prevention 6 (4), 201, 2013 | 34 | 2013 |
| Evaluation of growth inhibitory and apoptosis inducing activity of human calprotectin on the human gastric cell line (AGS) H Zali, TM REZAEI, A Kariminia, R Yousefi, MA Shokrgozar Iranian Biomedical Journal 12 (1), 7-14, 2008 | 30 | 2008 |
| Osteogenic differentiation potential of adipose-derived mesenchymal stem cells cultured on magnesium oxide/polycaprolactone nanofibrous scaffolds for improving bone tissue … Z Niknam, A Golchin, M Rezaei–Tavirani, P Ranjbarvan, H Zali, M Omidi, ... Advanced Pharmaceutical Bulletin 12 (1), 142, 2022 | 28 | 2022 |
| Effect of ELF-EMF exposure on human neuroblastoma cell line: a proteomics analysis H Hasanzadeh, M Rezaie-Tavirani, SS Seyyedi, H Zali, SH Keshel, ... Iranian journal of cancer prevention 7 (1), 22, 2014 | 27 | 2014 |
| FDA approved drugs repurposing of Toll-like receptor4 (TLR4) candidate for neuropathy H Zali, A Golchin, M Farahani, M Yazdani, MM Ranjbar, A Dabbagh Iranian Journal of Pharmaceutical Research: IJPR 18 (3), 1639, 2019 | 24 | 2019 |
| Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp S Fayazfar, H Zali, AA Oskouie, HA Aghdaei, MR Tavirani, EN Mojarad Gastroenterology and hepatology from bed to bench 12 (4), 328, 2019 | 22 | 2019 |
| Epidemiology and etiology of Alzheimer's disease Zali Hakimeh, Seyyedi Samaneh Sadat, Ali Rashidy Pour, Majid Rezaei Tavirani Koomesh 16 (2), 119-127, 2015 | 22* | 2015 |
| COMPARISON OF TWO STAINING ASSAYS; TRYPAN BLUE AND MTT IN VITRO EVALUATION OF HUMAN CALPROTECTIN PROLIFERATION INHIBITION ON HUMAN GASTRIC CANCER CELLS MA Shokrgozar, H Zali, TM Rezaei, A Amanzadeh KOWSAR MEDICAL JOURNAL 12 (2), 127-137, 2007 | 22 | 2007 |
| On the mechanism of apoptosis-inducing activity of human calprotectin: zinc sequestration, induction of a signaling pathway, or something else? H Zali, SA Marashi, M Rezaei-Tavirani, P Toossi, M Rahmati-Roodsari, ... Medical hypotheses 68 (5), 1012-1015, 2007 | 22 | 2007 |
| Prediction of Leishmania major key proteins via topological analysis of protein-protein interaction network NA Dashatan, MR Tavirani, H Zali, M Koushki, N Ahmadi Galen Medical Journal 7, e1129, 2018 | 21 | 2018 |
Mostafa Rezaei-TaviraniProfessor of Biophysics, Shahid Beheshti University of Medical Sciences, Tehran, IranVerificeret mail på sbmu.ac.ir
